Research Solutions Reports Fiscal Third Quarter 2021 Results
Research Solutions, Inc. (NASDAQ: RSSS) reported strong financial performance for its fiscal 2021 third quarter ending March 31, 2021. Key highlights include a 32% increase in platform revenue to $1.3 million, and annual recurring revenue rose 34% to $5.6 million. Total revenue grew 4% to $8.3 million. Net income improved to $50,000 compared to $12,000 a year prior, while adjusted EBITDA reached a record $238,000. Operating expenses were up by 4%, primarily due to increased technology and product development costs.
- Platform revenue increased 32% to $1.3 million.
- Annual recurring revenue rose 34% to $5.6 million.
- Net income improved to $50,000 from $12,000 year-over-year.
- Adjusted EBITDA reached a record $238,000, up 64% year-over-year.
- Operating expenses increased by 4% to $2.7 million, impacting profitability.
HENDERSON, Nev., May 13, 2021 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: RSSS), a pioneer in providing cloud-based workflow solutions for R&D driven organizations, reported financial results for its fiscal 2021 third quarter ended March 31, 2021.
Fiscal Third Quarter 2021 Highlights Compared to Prior Year Quarter:
- Platform revenue increased
32% to$1.3 million , Annual recurring revenue increased34% to$5.6 million - Total gross margin improved 80 basis points to
32.4% - Net income of
$50,000 , compared to net income of$12,000 in the prior-year quarter - Adjusted EBITDA of
$238,000 , an improvement of$93,000
"Our third quarter results include a pair of records within our Platforms business. We achieved 51 net new deployments for the quarter, and Annual Recurring Revenue increased by
Fiscal Third Quarter 2021 Results
Total revenue increased
Platform subscription revenue increased
Transaction revenue was
Total gross margin improved 80 basis points from the prior-year quarter to
Total operating expenses were
Net income in the third quarter was
Cash and cash equivalents on March 31, 2021 amounted to
Conference Call
Research Solutions Interim President and CEO Roy W. Olivier, Executive Chairman of the Board Peter Derycz and CFO Alan Urban will host the conference call, followed by a question and answer period.
Date: Thursday, May 13, 2021
Time: 5:00 p.m. ET (2:00 p.m. PT)
Toll-free dial-in number: 1-855-327-6837
International dial-in number: 1-631-891-4304
Conference ID: 10014529
The conference call will be broadcast live and available for replay until June 3, 2021, by dialing 1-844-512-2921 and using the replay ID 10014529, and via the investor relations section of the company's website at http://researchsolutions.investorroom.com/.
Fiscal Third Quarter Financial and Operational Summary Tables vs. Prior-Year Quarter
Quarter Ended March 31, | Nine Months Ended March 31, | |||||||||||||||||||||
2021 | 2020 | Change | % Change | 2021 | 2020 | Change | % Change | |||||||||||||||
Revenue: | ||||||||||||||||||||||
Platforms | ||||||||||||||||||||||
Transactions | 6,996,349 | 7,029,617 | (33,268) | - | 19,832,286 | 20,348,898 | (516,612) | - | ||||||||||||||
Total Revenue | 8,340,532 | 8,047,406 | 293,126 | 23,538,692 | 23,172,957 | 365,735 | ||||||||||||||||
Gross Profit: | ||||||||||||||||||||||
Platforms | 1,110,487 | 839,870 | 270,618 | 3,051,755 | 2,333,162 | 718,594 | ||||||||||||||||
Transactions | 1,592,153 | 1,699,144 | (106,991) | - | 4,492,043 | 4,796,187 | (304,144) | - | ||||||||||||||
Total Gross Profit | 2,702,640 | 2,539,014 | 163,627 | 7,543,798 | 7,129,349 | 414,450 | ||||||||||||||||
Gross profit as a % of revenue: | ||||||||||||||||||||||
Platforms | - | |||||||||||||||||||||
Transactions | - | - | ||||||||||||||||||||
Total Gross Profit | ||||||||||||||||||||||
Operating Expenses: | ||||||||||||||||||||||
Sales and marketing | 566,713 | 626,956 | (60,243) | - | 1,552,658 | 1,816,142 | (263,484) | - | ||||||||||||||
Technology and product development | 664,195 | 536,238 | 127,957 | 1,911,903 | 1,584,148 | 327,755 | ||||||||||||||||
General and administrative | 1,233,604 | 1,230,580 | 3,024 | 3,513,416 | 3,732,300 | (218,884) | - | |||||||||||||||
Depreciation and amortization | 2,066 | 5,510 | (3,444) | - | 8,828 | 19,908 | (11,080) | - | ||||||||||||||
Stock-based compensation | 179,345 | 142,237 | 37,108 | 786,084 | 808,541 | (22,457) | - | |||||||||||||||
Foreign currency translation loss | 6,648 | 8,648 | (2,000) | - | (35,070) | 15,315 | (50,385) | - | ||||||||||||||
Total Operating Expenses | 2,652,571 | 2,550,169 | 102,402 | 7,737,819 | 7,976,354 | (238,535) | - | |||||||||||||||
Income (loss) from operations | 50,069 | (11,155) | 61,225 | (194,020) | (847,005) | 652,985 | ||||||||||||||||
Other Income (Expenses): | ||||||||||||||||||||||
Other income (expense) | 250 | 23,662 | (23,412) | - | 884 | 75,738 | (74,854) | - | ||||||||||||||
Provision for income taxes | (572) | (561) | (11) | - | (3,077) | (7,861) | 4,784 | |||||||||||||||
Gain on sale of disc'd operations | - | - | - | - | 117,445 | (117,445) | - | |||||||||||||||
Total Other Income (Expenses): | (322) | 23,101 | (23,423) | - | (2,193) | 185,322 | (187,515) | - | ||||||||||||||
Net income (loss) | $ 49,747 | $ 11,946 | 37,802 | - | $ (196,213) | $ (661,683) | 465,470 | |||||||||||||||
Quarter Ended March 31, | Nine Months Ended March 31, | |||||||||||||||||||||
2021 | 2020 | Change | % Change | 2021 | 2020 | Change | % Change | |||||||||||||||
Platforms: | ||||||||||||||||||||||
ARR (Annual recurring revenue): | ||||||||||||||||||||||
Beginning of Period | $ 1,303,254 | |||||||||||||||||||||
Incremental ARR | 533,541 | 432,030 | 101,511 | 1,108,507 | 925,158 | 183,349 | ||||||||||||||||
End of Period | $ 1,404,765 | |||||||||||||||||||||
Deployments: | ||||||||||||||||||||||
Beginning of Period | 461 | 338 | 123 | 401 | 301 | 100 | ||||||||||||||||
Incremental Deployments | 51 | 36 | 15 | 111 | 73 | 38 | ||||||||||||||||
End of Period | 512 | 374 | 138 | 512 | 374 | 138 | ||||||||||||||||
ASP (Average sales price): | ||||||||||||||||||||||
Beginning of Period | $ 10,892 | $ 10,999 | $ (108) | - | $ 11,088 | $ 10,713 | $ 374 | |||||||||||||||
End of Period | $ 10,849 | $ 11,096 | $ (247) | - | $ 10,849 | $ 11,096 | $ (247) | - | ||||||||||||||
Transaction Customers: | ||||||||||||||||||||||
Corporate customers | 841 | 845 | (4) | - | 818 | 851 | (33) | - | ||||||||||||||
Academic customers | 267 | 270 | (3) | - | 284 | 278 | 6 | |||||||||||||||
Total customers | 1,108 | 1,115 | (7) | - | 1,102 | 1,129 | (27) | - | ||||||||||||||
Active Customer Accounts, Transactions and Annual Recurring Revenue
The company defines active customer accounts as the sum of the total quantity of customers per month for each month in the period divided by the respective number of months in the period. The quantity of customers per month is defined as customers with at least one transaction during the month.
A transaction is an order for a unit of copyrighted content fulfilled or managed in the Platform.
The company defines annual recurring revenue as the value of contracted Platform subscription recurring revenue normalized to a one-year period.
Use of Non-GAAP Measure – Adjusted EBITDA
Research Solutions' management evaluates and makes operating decisions using various financial metrics. In addition to the company's GAAP results, management also considers the non-GAAP measure of Adjusted EBITDA. Management believes that this non-GAAP measure provides useful information about the company's operating results.
The tables below provide a reconciliation of this non-GAAP financial measure with the most directly comparable GAAP financial measure. Adjusted EBITDA is defined as net income (loss), plus interest expense, other income (expense), foreign currency transaction loss, provision for income taxes, depreciation and amortization, stock-based compensation, gain on sale of discontinued operations, and other potential adjustments that may arise. Set forth below is a reconciliation of Adjusted EBITDA to net income (loss):
Quarter Ended March 31, | Nine Months Ended March 31, | |||||||||
2021 | 2020 | Change | % Change | 2021 | 2020 | Change | % Change | |||
Net Income (loss) | $ 49,747 | $ 11,946 | $ 37,802 | $ (196,213) | $ (661,683) | $ 465,470 | ||||
Add (deduct): | - | |||||||||
Other income (expense) | (250) | (23,662) | 23,412 | (884) | (75,738) | 74,854 | ||||
Foreign currency translation loss | 6,648 | 8,648 | (2,000) | - | (35,070) | 15,315 | (50,385) | - | ||
Provision for income taxes | 572 | 561 | 11 | 3,077 | 7,861 | (4,784) | - | |||
Depreciation and amortization | 2,066 | 5,510 | (3,444) | - | 8,828 | 19,908 | (11,080) | - | ||
Stock-based compensation | 179,345 | 142,237 | 37,108 | 786,084 | 808,541 | (22,457) | - | |||
Gain on sale of disc. ops. | - | - | - | - | (117,445) | 117,445 | ||||
Adjusted EBITDA | $ 238,128 | $ 145,240 | $ 92,889 | $ 565,822 | $ (3,241) | $ 569,063 |
About Research Solutions and Reprints Desk
Research Solutions, Inc. (NASDAQ: RSSS) is a pioneer in providing seamless access and simplifies how organizations and individual researchers discover, acquire, and manage scholarly journal articles, book chapters and other content in scientific, technical, and medical (STM) research. More than 70 percent of the top pharmaceutical companies, prestigious universities, and emerging businesses rely on Article Galaxy, a cloud-based SaaS research platform, for simplified and lowest cost access to the latest scientific research and data. Featuring an ecosystem of app-like Gadgets for a personalized research experience, Article Galaxy offers individual as well as enterprise plans, coupled with unparalleled, 24/7 customer support. For more information and details, please visit www.researchsolutions.com and www.reprintsdesk.com
Important Cautions Regarding Forward-Looking Statements
Certain statements in this press release may contain "forward-looking statements" regarding future events and our future results. All statements other than statements of historical facts are statements that could be deemed to be forward-looking statements. These statements are based on current expectations, estimates, forecasts, and projections about the markets in which we operate and the beliefs and assumptions of our management. Words such as "expects," "anticipates," "targets," "goals," "projects", "intends," "plans," "believes," "seeks," "estimates," "endeavors," "strives," "may," or variations of such words, and similar expressions are intended to identify such forward-looking statements. Readers are cautioned that these forward-looking statements are subject to a number of risks, uncertainties and assumptions that are difficult to predict, estimate or verify. Therefore, actual results may differ materially and adversely from those expressed in any forward-looking statements. Such risks and uncertainties include those factors described in the Company's most recent annual report on Form 10-K, as such may be amended or supplemented by subsequent quarterly reports on Form 10-Q, or other reports filed with the Securities and Exchange Commission. Examples of forward-looking statements in this release include statements regarding continued momentum in the Company's business andsales initiatives. Readers are cautioned not to place undue reliance on these forward-looking statements. The forward-looking statements are made only as of the date hereof, and the Company undertakes no obligation to publicly release the result of any revisions to these forward-looking statements. For more information, please refer to the Company's filings with the Securities and Exchange Commission.
Research Solutions, Inc. and Subsidiaries Condensed Consolidated Balance Sheets | |||||||
March 31, | |||||||
2021 | June 30, | ||||||
(unaudited) | 2020 | ||||||
Assets | |||||||
Current assets: | |||||||
Cash and cash equivalents | $ | 11,233,562 | $ | 9,311,556 | |||
Accounts receivable, net of allowance of | 5,013,089 | 4,449,260 | |||||
Prepaid expenses and other current assets | 317,220 | 241,747 | |||||
Prepaid royalties | 743,513 | 720,367 | |||||
Total current assets | 17,307,384 | 14,722,930 | |||||
Other assets: | |||||||
Property and equipment, net of accumulated depreciation of | 15,165 | 11,276 | |||||
Deposits and other assets | 878 | 6,155 | |||||
Right of use asset, net of accumulated amortization of | — | 72,331 | |||||
Total assets | $ | 17,323,427 | $ | 14,812,692 | |||
Liabilities and Stockholders' Equity | |||||||
Current liabilities: | |||||||
Accounts payable and accrued expenses | $ | 7,558,319 | $ | 6,349,845 | |||
Deferred revenue | 4,601,473 | 3,524,507 | |||||
Lease liability, current portion | — | 79,326 | |||||
Total current liabilities | 12,159,792 | 9,953,678 | |||||
Commitments and contingencies | |||||||
Stockholders' equity: | |||||||
Preferred stock; | — | — | |||||
Common stock; | 26,352 | 26,032 | |||||
Additional paid-in capital | 26,631,985 | 26,134,819 | |||||
Accumulated deficit | (21,373,012) | (21,176,799) | |||||
Accumulated other comprehensive loss | (121,690) | (125,038) | |||||
Total stockholders' equity | 5,163,635 | 4,859,014 | |||||
Total liabilities and stockholders' equity | $ | 17,323,427 | $ | 14,812,692 |
Research Solutions, Inc. and Subsidiaries Condensed Consolidated Statements of Operations and Other Comprehensive Income (Loss) (Unaudited) | |||||||||||||
Three Months Ended | Nine Months Ended | ||||||||||||
March 31, | March 31, | ||||||||||||
2021 | 2020 | 2021 | 2020 | ||||||||||
Revenue: | |||||||||||||
Platforms | $ | 1,344,183 | $ | 1,017,789 | $ | 3,706,406 | $ | 2,824,059 | |||||
Transactions | 6,996,349 | 7,029,617 | 19,832,286 | 20,348,898 | |||||||||
Total revenue | 8,340,532 | 8,047,406 | 23,538,692 | 23,172,957 | |||||||||
Cost of revenue: | |||||||||||||
Platforms | 233,696 | 177,919 | 654,651 | 490,897 | |||||||||
Transactions | 5,404,196 | 5,330,473 | 15,340,243 | 15,552,711 | |||||||||
Total cost of revenue | 5,637,892 | 5,508,392 | 15,994,894 | 16,043,608 | |||||||||
Gross profit | 2,702,640 | 2,539,014 | 7,543,798 | 7,129,349 | |||||||||
Operating expenses: | |||||||||||||
Selling, general and administrative | 2,650,504 | 2,544,659 | 7,728,990 | 7,956,446 | |||||||||
Depreciation and amortization | 2,066 | 5,510 | 8,828 | 19,908 | |||||||||
Total operating expenses | 2,652,570 | 2,550,169 | 7,737,818 | 7,976,354 | |||||||||
Income (loss) from operations | 50,070 | (11,155) | (194,020) | (847,005) | |||||||||
Other income | 250 | 23,662 | 884 | 75,738 | |||||||||
Income (loss) from operations before provision for income taxes | 50,320 | 12,507 | (193,136) | (771,267) | |||||||||
Provision for income taxes | (572) | (561) | (3,077) | (7,861) | |||||||||
Income (loss) from continuing operations | 49,748 | 11,946 | (196,213) | (779,128) | |||||||||
Gain from sale of discontinued operations | — | — | — | 117,445 | |||||||||
Net income (loss) | 49,748 | 11,946 | (196,213) | (661,683) | |||||||||
Other comprehensive income (loss): | |||||||||||||
Foreign currency translation | (3,333) | (14,677) | 3,348 | (16,702) | |||||||||
Comprehensive income (loss) | $ | 46,415 | $ | (2,731) | $ | (192,865) | $ | (678,385) | |||||
Basic income (loss) per common share: | |||||||||||||
Income (loss) per share from continuing operations | $ | 0.00 | $ | — | $ | (0.01) | $ | (0.03) | |||||
Income per share from discontinued operations | $ | — | $ | — | $ | — | $ | — | |||||
Net income (loss) per share | $ | 0.00 | $ | — | $ | (0.01) | $ | (0.03) | |||||
Basic weighted average common shares outstanding | 26,027,665 | 24,960,394 | 25,966,072 | 24,411,888 | |||||||||
Diluted income (loss) per common share: | |||||||||||||
Income (loss) per share from continuing operations | $ | 0.00 | $ | — | $ | (0.01) | $ | (0.03) | |||||
Income per share from discontinued operations | $ | — | $ | — | $ | — | $ | — | |||||
Net income (loss) per share | $ | 0.00 | $ | — | $ | (0.01) | $ | (0.03) | |||||
Diluted weighted average common shares outstanding | 26,565,892 | 25,717,403 | 25,966,072 | 24,411,888 |
View original content to download multimedia:http://www.prnewswire.com/news-releases/research-solutions-reports-fiscal-third-quarter-2021-results-301291261.html
SOURCE Research Solutions, Inc.
FAQ
What were the third quarter 2021 earnings results for Research Solutions (RSSS)?
How did platform revenue perform in the third quarter of 2021 for RSSS?
What is the annual recurring revenue for Research Solutions as of March 31, 2021?